Suppression of experimental autoimmune uveoretinitis by anti-alphabeta TCR monoclonal antibody

Jpn J Ophthalmol. 2002 Sep-Oct;46(5):518-24. doi: 10.1016/s0021-5155(02)00538-5.

Abstract

Purpose: To evaluate the effects of anti-alphabeta T cell receptor monoclonal antibody (R73) on the induction of experimental autoimmune uveoretinitis (EAU) in rats.

Methods: Lewis rats in which EAU was induced were treated with R73. All rats were examined for the clinical course of EAU, pathological findings of the globe, delayed-type hypersensitivity, and the interleukin-2 (IL-2) gene and protein expression in the eye.

Results: The R73 treatment was effective for delaying EAU onset, decreasing the severity of EAU, and suppressing delayed-type hypersensitivity to the antigen. IL-2 gene and protein expression was reduced by R73 treatment in the anterior and posterior segments of the eye.

Conclusion: R73 treatment is effective for suppression of the development of EAU, inhibiting IL-2 expression in the eye.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / therapeutic use*
  • Aqueous Humor / metabolism
  • Arrestin / immunology
  • Autoimmune Diseases / drug therapy*
  • Autoimmune Diseases / immunology
  • Choroid / physiopathology
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Hypersensitivity, Delayed / immunology
  • Immunohistochemistry
  • Interleukin-2 / genetics
  • Interleukin-2 / metabolism
  • Iris / physiopathology
  • Osmolar Concentration
  • Rats
  • Rats, Inbred Lew
  • Receptors, Antigen, T-Cell, alpha-beta / immunology*
  • Retina / physiopathology
  • Retinitis / drug therapy*
  • Retinitis / immunology
  • Transcription, Genetic
  • Uveitis / drug therapy*
  • Uveitis / immunology

Substances

  • Antibodies, Monoclonal
  • Arrestin
  • Interleukin-2
  • Receptors, Antigen, T-Cell, alpha-beta